Cancer

Cancer research

Our cancer research theme brings together laboratory scientists, clinicians and practitioners to link our biomedical research with clinical, health and social care, and public health applications.

Underpinned by our bench to bedside and back again approach to translational medicine this research aims to deliver impact and patient / public benefit through:

  • Investigation of the underlying mechanisms by which cancers are initiated and propagate;
  • Development of new approaches for the early diagnosis, screening, treatment and prevention of a variety of cancers and;
  • Understanding the impact and effectiveness of frontline treatments on practice.

Cancer research forms part of our Clinician led medical research, Public health and Oral health and disease research and features the University of Plymouth's internationally renowned Brain Tumour Research Centre of Excellence.

Clinical trials and complex studies in these areas are supported by our UKCRC registered Peninsula Clinical Trials Unit (PenCTU).

Delivery of our research and work with external partners is facilitated by our:


March is Brain Tumour Awareness Month 

The University is recognised as a Brain Tumour Research Centre of Excellence. It is one of only four in the UK with a unique focus on low-grade brain tumours.

Professor Oliver Hanemann and his dedicated team of researchers at the Institute of Translational and Stratified Medicine HQ are carrying out world-leading research to discover treatments and ultimately, a cure for brain tumours.

Join us this March in the fight to raise awareness and vital funds to help save lives. 

Our research

The cancer theme encompasses:





Contact us

For more information about our Cancer research please contact the research leads indicated for specific areas of interest.

General enquiries: meddent-research@plymouth.ac.uk.

IP, tech transfer and commercial enquiries: Dr Tom Nicholson (Research & Innovation Business Partner) or Dr David Mozley (IP Specialist Adviser)